80
Participants
Start Date
September 17, 2024
Primary Completion Date
December 30, 2025
Study Completion Date
May 30, 2026
Intravenous administered opioid
Hydromorphone will be received intravenously using a patient controlled administration pump, as well as patient will have a continuous bupivacaine epidural infusion
Epidural administered opioid
Hydromorphone will be added to the bupivacaine in the epidural and will have a continuous infusion along with the ability for the patient to receive epidural boluses of the medications by a patient controlled epidural administration pump
RECRUITING
University of Iowa Health Care, Iowa City
University of Iowa
OTHER